Decompensated Heart Failure Clinical Trial
— ERICOfficial title:
Rehabilitation Nursing on Patients Admitted by Recently Decompensated Heart Failure (ERIC Program) - Impact of Exercise
Verified date | September 2017 |
Source | Universidade do Porto |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
An aerobic physical exercise protocol will be applied to patients admitted in ward due to decompensated heart failure, in order to validate the efficacy and safety of physical exercise in this phase of clinical stabilization, through the said training protocol - ERIC program.
Status | Completed |
Enrollment | 250 |
Est. completion date | September 30, 2019 |
Est. primary completion date | March 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Admission diagnosis of Decompensated heart failure - More than 18 years old - Capacity to provide informed consent Exclusion Criteria: - Osteoarticular pathology that impedes the performance of the exercise - Existence of inotropic infusions - Dysrhythmia or precordial pain in the last 24 hours - Acute pulmonary edema in the last 12 hours - Systolic blood pressure greater than 180millimetre of mercury (mmHg) or less than 80mmHg (except in cases where this is the baseline value for the patient) - Need for oxygen at a rate greater than 3 /min - Glycemic decompensation in the last 12 hours |
Country | Name | City | State |
---|---|---|---|
Portugal | Centro Hospitalar do Porto | Oporto |
Lead Sponsor | Collaborator |
---|---|
Universidade do Porto | Centro Hospitalar do Porto, Instituto Politécnico de Bragança |
Portugal,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 6 minute walking test | Number of meters walked in the 6 minute walking test | through study completion, an average of 1 year | |
Secondary | Barthel Index score | Barthel evaluates dependence on self-care | through study completion, an average of 1 year | |
Secondary | London Chest Activity of Daily Living (LCADL) scale score | LIDL accesses how dyspnea affects self-care | through study completion, an average of 1 year | |
Secondary | Number of dysrhythmias during exercise in the training group | To quantify the number of dysrhythmias during exercise in the training group | through study completion, an average of 1 year | |
Secondary | Number of falls during exercise in the training group | To quantify the number of falls during exercise in the training group | through study completion, an average of 1 year | |
Secondary | Number of emergency situations during exercise in the training group | To quantify the number of emergency situations during exercise in the training group | through study completion, an average of 1 year | |
Secondary | Number of chest pain situations during exercise in the training group | To quantify the chest pain situations during exercise in the training group | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05910437 -
Optimizing Treatments for Heart Failure During Hospitalization
|
||
Terminated |
NCT00355017 -
BNP Guided Care in Addition to Multidisciplinary Care
|
N/A | |
Active, not recruiting |
NCT03701880 -
Early Use of Ivabradine in Heart Failure
|
N/A | |
Recruiting |
NCT03157219 -
Manipal Heart Failure Registry (MHFR)
|
N/A | |
Recruiting |
NCT06114498 -
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
|
||
Completed |
NCT02997462 -
Monocyte Phenotypic Changes in Heart Failure
|
||
Completed |
NCT04493346 -
Shear Wave Elastography
|
||
Recruiting |
NCT02666651 -
Regional Tolvaptan Registry
|
Phase 4 | |
Recruiting |
NCT02236247 -
Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06273397 -
Acetazolamide or Metolazone in Acute Heart Failure
|
N/A | |
Completed |
NCT05927285 -
Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1
|
N/A | |
Withdrawn |
NCT04572867 -
Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure
|
N/A | |
Completed |
NCT02157506 -
A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure
|
Phase 2 | |
Recruiting |
NCT03914222 -
Comparing PA Compliance During and After Decompensation in HFP
|
N/A | |
Recruiting |
NCT06286423 -
Colchicine in Acutely Decompensated HFREF
|
Phase 4 | |
Recruiting |
NCT03009552 -
Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure
|
N/A | |
Completed |
NCT04019314 -
Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI)
|
N/A | |
Recruiting |
NCT02649517 -
Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated HF With Ischemic Systolic Dysfunction
|
N/A | |
Recruiting |
NCT03440970 -
Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure
|
Early Phase 1 | |
Recruiting |
NCT05090930 -
Innovative Technologies for the Treatment of Pulmonary and Heart Failure
|
N/A |